insulin
Glenmark Pharma Launches Combination Drug For Type 2 Diabetic Patients
Banking - Published date: .
Glenmark Pharmaceuticals Ltd on Wednesday said it has launched triple fixed-dose combination Teneligliptin with Pioglita... Read more
Biocon's US Prospects Get A Boost After Company Receives EIR From USFDA
Banking - Published date: .
The insulin patent win, clearance of Malaysian unit and oncology biosimilar filing are triggers Read more